Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.11 USD | +0.16% | +11.52% | +64.04% |
19/04 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
28/03 | Truist Securities Initiates Coverage on Merus With Buy Rating, $69 Price Target | MT |
Evolution of the average Target Price on Merus N.V.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Merus N.V.
Truist Securities | |
Needham & Co. | |
Stifel Nicolaus | |
TD Cowen | |
Citigroup | |
HC Wainwright | |
BMO Capital | |
SVB Securities LLC | |
Guggenheim | |
EF Hutton | |
RBC Capital Markets | |
SVB Leerink | |
Roth Capital Partners | |
William Blair & Co. |
EPS Revisions
- Stock Market
- Equities
- MRUS Stock
- Consensus Merus N.V.